An experienced leadership team

Our leadership team understands the complexities of antibody engineering, cancer biology, immunology, cell-line and bioprocess development, purification process development and analytics. They have a proven track record of innovation and success, including numerous issued patents. These leaders have led the development of multiple biotherapies that progressed to clinical testing.

Wei Yan, Ph.D.

Chief Executive Officer

William Fanslow, Ph.D.

Executive Vice President, R&D

Ronald Schoner, Ph.D.

Vice President, Bioprocess Sciences

Paul Algate, Ph.D.

Senior Director, Biology

Phillip Liu, M.D.

Director, Antibody Engineering